Cargando…
Effect of Bevacizumab Treatment in Cerebral Radiation Necrosis : Investigation of Response Predictors in a Single-Center Experience
OBJECTIVE: Bevacizumab is a feasible option for treating cerebral radiation necrosis (RN). We investigated the clinical outcome of RN after treatment with bevacizumab and factors related to the initial response and the sustained effect. METHODS: Clinical data of 45 patients treated for symptomatic R...
Autores principales: | Lee, Shin Heon, Choi, Jung Won, Kong, Doo-Sik, Seol, Ho Jun, Nam, Do-Hyun, Lee, Jung-Il |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neurosurgical Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483166/ https://www.ncbi.nlm.nih.gov/pubmed/36642947 http://dx.doi.org/10.3340/jkns.2022.0229 |
Ejemplares similares
-
The Influence of Biomarker Mutations and Systemic Treatment on Cerebral Metastases from NSCLC Treated with Radiosurgery
por: Lee, Min Ho, et al.
Publicado: (2017) -
Clinical Experience of Bevacizumab for Radiation Necrosis in Patients with Brain Metastasis
por: Park, Moowan, et al.
Publicado: (2020) -
Clinical outcomes of patients with multiple courses of radiosurgery for brain metastases from non-small cell lung cancer
por: Lee, Won-Jae, et al.
Publicado: (2022) -
Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients
por: Wang, Yang, et al.
Publicado: (2012) -
Clinical and Radiological Characteristics of Angiomatous Meningiomas
por: Hwang, Juyoung, et al.
Publicado: (2016)